FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
For Immediate Release: February 25, 2010
Association of Community Cancer Centers to Honor New Jersey Community Oncologist Carl J. Minniti, Jr., MD
ROCKVILLE, Md.—Carl J. Minniti, Jr., MD, will be honored with the Association of Community Cancer Centers' annual David King Community Clinical Scientist Award for his outstanding service, leadership, and commitment to the oncology community. Dr. Minniti practices medical oncology and hematology in a single specialty group practice in Mickleton, N.J.
Over his long career, Dr. Minniti has coordinated research efforts, opened numerous clinical studies, and has demonstrated the ability for significant protocol accrual to cooperative group trials. He is a firm believer that excellence in cancer care requires a dedication to clinical research, balanced with compassionate care, faith, and hope for patients and their families.
The award will be presented at ACCC's 36th Annual National Meeting on Thursday, March 18, 2010, at the Baltimore Marriott Waterfront Hotel in Baltimore, Md. The David King Community Clinical Scientist Award recognizes active community clinical research leaders. Award winners have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.
After completing his fellowship in oncology and hematology at Fox Chase Cancer Center in 1992, Dr. Minniti returned to his suburban roots to enhance a hematology practice that was started by his father, Dr. Carl Minniti, Sr., 30 years earlier. Together, they designed and constructed a state-of-the-art facility for the delivery of multidisciplinary oncology care to the local community. Through a network affiliation with Fox Chase Cancer Center, he is able to offer his patients participation in a variety of clinical trials. Dr. Minniti has been closely associated with the American Cancer Society for the last 15 years as both a volunteer and a past president, coordinating patient care services, screening programs, and fund raising activities.
ACCC's prestigious award is named after David K. King, MD, FACP, who passed away after a brief battle with cancer. Dr. King had a long and colorful history with the Association of Community Cancer Centers, serving in many capacities—president, chair of ACCC’s Annual Presidents' Retreat, and co-chair of ACCC’s reimbursement committee, just to name a few. Dr. King spent his entire life caring for individuals with cancer and advocating for access to quality care, while also championing the Community Clinical Oncology Program and the value of clinical research in the community setting. Award winners become lifetime members of the ACCC National Academy of Community Oncology Scientists, which will serve as a valuable resource to ACCC, NCI, pharmaceutical companies, and other organizations involved in community cancer research.